A University of Glasgow spinout which is bringing to market a fast, affordable and efficient new way to diagnose diseases has received a major funding boost. Innovate UK, the UK’s innovation agency, has announced a £1.5m grant in support of SAW Dx, an emerging biological sample analysis and point of care diagnostic company founded by University of Glasgow biomedical engineers. The grant, which requires a...
Researchers at the University of Strathclyde have developed an innovative, low cost test for earlier diagnosis of sepsis which could save thousands of lives. The simple system for sensitive real-time measurement of the life threatening condition is much quicker than existing hospital tests, which can take up to 72 hours to process. Using a microelectrode, a biosensor device is used to detect if one of...
DIHS, a medical education centre formed by the University of Dundee, NHS Tayside and industry partners Medtronic, are developing the first training programme for robotic-assisted surgery in Scotland. Surgical robots are used to carry out operations across four health boards in Scotland, but surgeons must travel to England or overseas to be trained in their use. The installation of the £1.7 million da Vinci robot...
Data from the world’s largest research project into the prevention of Alzheimer’s will be stored on Microsoft’s cloud platform following a new agreement with Aridhia. The Scottish company, whose digital research platform AnalytiXagility is used in the health, biomedical research and precision medicine sectors, is to move all its work to Azure, including treatment studies by the European Prevention of Alzheimer’s Dementia Consortium (EPAD). Aridhia will use Microsoft’s service...
Invizius, the Edinburgh spinout whose technology promises to improve the lives of millions of dialysis patients, has been named Best Innovative MedTech company at the prestigious OBN Awards. The company’s success in the awards, which have a high profile in the life sciences sector, follows on from a seed investment of £500,000 from Mercia Fund Managers in May 2018. Reducing risk Invizius’ H-Guard™ product acts...
An Edinburgh-based stem cell research business has landed a seven-figure funding boost allowing for expansion of its exploratory services, which include tackling diseases such as Parkinson’s and Alzheimer’s. Censo Biotechnologies has secured a £1.3 million investment to help broaden the stem cell research services it supplies to pharmaceutical companies developing new treatments for a range of diseases. The firm creates technology to produce stem cells...